Tenon Medical Sets Date for Third Quarter 2026 Financial Results
Tenon Medical plans to release its financial results for the third quarter ended September 30, 2026, on November 12, 2026, with an earnings call scheduled for later that day.
Tenon Medical, Inc. (NASDAQ:TNON) plans to publish its financial results for the third quarter ended September 30, 2026, after market close on Thursday, November 12, 2026. The company will discuss the results during a conference call scheduled for 4:30 p.m. Eastern Time on the same day.
The call will include a question-and-answer session with Tenon Medical’s covering analysts. Participants are asked to dial in at least 10 minutes before the scheduled start to support timely access.
Tenon Medical said an audio replay will remain available through November 26, 2026, through its Investor Relations website and telephone replay service.
Tenon Medical is a medical device company focused on patients with certain sacro-pelvic disorders. It currently offers two systems for treating a diseased sacroiliac joint, also known as the SI Joint.
The company’s portfolio includes The Catamaran™ SI Joint Fusion System, which uses a single titanium implant in a less invasive approach, and the SImmetry+® SI Joint Fusion System, which uses minimally invasive lateral access and established orthopaedic fusion principles.
Tenon Medical was incorporated in Delaware in 2012. In August 2025, it acquired substantially all of the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+® system.
Following the national launch of The Catamaran System in October 2022, the company has focused on primary SI Joint procedures, revisions involving failed SI Joint implants, and SI-Joint fusion used as an adjunct to a spine fusion construct.
Tenon Medical, Inc. announced plans to release its financial results for the third quarter ended September 30, 2026, and to hold a conference call to discuss them.
Tenon Medical, Inc. plans to release the results after market close on Thursday, November 12, 2026.
Tenon Medical, Inc. plans to hold the conference call on Thursday, November 12, 2026, at 4:30 p.m. Eastern Time. The call will include a question-and-answer session with its covering analysts.
Investors can access the call by dialling in at least 10 minutes before it starts to ensure timely participation. Tenon Medical, Inc. did not provide a dial-in telephone number in the announcement for the live call.
Tenon Medical, Inc. said an audio playback will be available through November 26, 2026, on its Investor Relations website or by telephone replay.
The telephone replay can be accessed by dialling 1-844-512-2921 in the USA or 1-412-317-6671 internationally, using access code 13763354.
Tenon Medical, Inc. trades on NASDAQ under the ticker symbol TNON.
Tenon Medical, Inc. is a medical device company focused on transforming care for patients with certain sacro-pelvic disorders. The company currently offers two systems to treat a diseased sacroiliac joint, or SI Joint.
Tenon Medical, Inc. offers The Catamaran™ SI Joint Fusion System and the SImmetry+® SI Joint Fusion System. The Catamaran System uses a single titanium implant in a less invasive approach, while SImmetry+ uses a minimally invasive lateral access solution incorporating established orthopaedic fusion principles.
Since the national launch of The Catamaran System in October 2022, Tenon Medical, Inc. has focused on primary SI Joint procedures, revision procedures for failed SI Joint implants, and SI-Joint fusion adjunct procedures to a spine fusion construct.